GRANIX (TBO-FILGRASTIM) INJECTION Trademark

Trademark Overview

On Friday, August 16, 2013, a trademark application was filed for GRANIX (TBO-FILGRASTIM) INJECTION with the United States Patent and Trademark Office. The USPTO has given the GRANIX (TBO-FILGRASTIM) INJECTION trademark a serial number of 86040024. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, June 18, 2015. This trademark is owned by TEVA Pharmaceutical Industries Limited. The GRANIX (TBO-FILGRASTIM) INJECTION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceuticals used to stimulate white blood cell production, all containing filgrastim
granix (tbo-filgrastim) injection

General Information

Serial Number86040024
Word MarkGRANIX (TBO-FILGRASTIM) INJECTION
Filing DateFriday, August 16, 2013
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, June 18, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 1, 2014

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"INJECTION"
Description of MarkThe mark consists of the stylized word "GRANIX" appearing above the stylized wording "(TBO-FILGRASTIM)", which is above the stylized word "INJECTION".
Goods and ServicesPharmaceutical preparations, namely, pharmaceuticals used to stimulate white blood cell production, all containing filgrastim

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 24, 2013
Primary Code005
First Use Anywhere DateSaturday, November 30, 2013
First Use In Commerce DateSaturday, November 30, 2013

Trademark Owner History

Party NameTEVA Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTEVA Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Thursday, June 18, 2015ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, June 18, 2015ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, November 20, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 20, 2014NON-FINAL ACTION E-MAILED
Thursday, November 20, 2014SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 29, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, October 3, 2014USE AMENDMENT FILED
Tuesday, October 21, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 3, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, May 27, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 1, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 27, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, February 26, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 26, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, February 26, 2014EXAMINERS AMENDMENT -WRITTEN
Saturday, February 15, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, January 12, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, December 30, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 30, 2013ASSIGNED TO LIE
Wednesday, December 4, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, December 4, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 4, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, December 4, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 3, 2013ASSIGNED TO EXAMINER
Saturday, August 24, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 20, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

injection filgrastim granix cell blood production containing white stimulate preparations namely pharmaceuticals